Drug Type Small molecule drug |
Synonyms IRBM-Z-2 |
Target |
Action inhibitors |
Mechanism NS2B/NS3 inhibitors(NS2B/NS3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Zika Virus Infection | Preclinical | Italy | 10 Feb 2026 |





